Trial Profile
Telmisartan versus amlodipine in hypertensive patients with paroxymal atrial fibrillation and different left atrial sizes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine
- Indications Hypertension; Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
- 12 Jun 2011 New trial record